Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLY-686 for treatment-resistant pruritus associated with atopic dermatitis
2013-002931-25Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing VLY-686 with Placebo (2 arms). Primary endpoint: Mean change from baseline in pruritus intensity relative to placebo at endpoint according to the Visual Analogue Scale. Started Aug 2013; status: completed.
02
Drugs
tradipitant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2013-002931-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002931-25.